Renowned researchers and leaders in cancer immunotherapeutics have confirmed their participation at theupcoming "Cancer Immunotherapy" conference program atCHI's 2nd Annual PEGS Korea Summit, scheduled to take place September 20-22, 2016 in Seoul, Korea.

This new conference will feature renowned international scientist from US, Europe, Japan, China and Korea. The meeting will kickoff with an opening Keynote Session showcasing Dr. Philip Gotwals, Executive Director, Exploratory Immuno-Oncology at Novartis Institutes of Biomedical Resesarch and Dr. Patrick Baeuerle, Managing Director of MPM Capital.

Discussing Cancer Treatment by Targeted Activation of the Immune System, Dr. Gotwals will illustrate therapeutic approaches with immune-based therapies using examples from Novartis immuno-oncology pipeline.

Dr. Patrick Baeuerle will explore the MOA of T cell-engaging antibodies for cancer therapy, covering all necessary steps including bispecific binding, T cell activation, serial lysis, T cell expansion, tumor eradication, bystander effect, epitope spreading and the impact of immune escape mechanism.

Other distinguished speakers include Keiya Ozawa of University of Tokyo;Inpyo Choi of KRIBB; Zhengping Zhu of Kadmon Corporation; Tom Igawa of Chugai Pharmaceuticals; Weikang Tao of Jiangsu Hengrui; YW Park of Y Biologics; Chengbin Wu of Epimab; JinSan Yoo of PharmAbcine; Amer Alghabban of Karyopharm US and more!

Get the full list of topics and speakers atPEGSummitkorea.com/Cancer-Immunotherapy.

To make the best of your time at the event and optimize your learning opportunity, consider attending the accompanying "Protein & Antibody Engineering" conference to learn about antibodies and vaccines for infectious diseases, emerging target discovery and validation, ADC design, and more.

Plus, attend the dinner short course on "Troubleshooting and Engineering of Antibody Constructs" to learn about antibody engineering strategies in screening and initial characterization phase to avoid costly and time-consuming bottlenecks in later-stage development.

For Registration and Pricing Options:

Call toll free: +1-888-999-6288

Visit: https://chidb.com/reg/abk/reg.asp

Contact: David Cunningham for Group Discounts at 781-972-5472

I look forward to meeting you at this event.

Sincerely,

Mimi Langley

Senior Conference Director

Cambridge Healthtech Institute